Resveratrol and cancer: a review

被引：169

作者：

Savouret, JF ^{[1
]}

Quesne, M ^{[1
]}

机构：

[1] CHU Le Kremlin Bicetre, Hop Bicetre, INSERM U135, F-94270 Le Kremlin Bicetre, France

来源：

BIOMEDICINE & PHARMACOTHERAPY | 2002年 / 56卷 / 02期

关键词：

aryl hydrocarbon receptor; chemoprevention; resveratrol;

D O I：

10.1016/S0753-3322(01)00158-5

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

The various properties of the stilbene phytoalexin Resveratrol provide interesting new avenues of research in the field of chemoprevention and chemotherapy. A particular emphasis is given on xenobiotic-related carcinogenesis. (C) 2002 Editions scientifiques et medicales Elsevier SAS.

引用

页码：84 / 87

页数：4

共 40 条

[21] Chemoprevention by inducers of carcinogen detoxication enzymes [J].

Kensler, TW .

ENVIRONMENTAL HEALTH PERSPECTIVES, 1997, 105 :965-970

[22] PRODUCTION OF RESVERATROL BY VITIS-VINIFERA AND OTHER MEMBERS OF VITACEAE AS A RESPONSE TO INFECTION OR INJURY [J].

LANGCAKE, P ;

PRYCE, RJ .

PHYSIOLOGICAL PLANT PATHOLOGY, 1976, 9 (01) :77-86

[23] 4-HYDROXYLATION OF ESTRADIOL BY HUMAN UTERINE MYOMETRIUM AND MYOMA MICROSOMES - IMPLICATIONS FOR THE MECHANISM OF UTERINE TUMORIGENESIS [J].

LIEHR, JG ;

RICCI, MJ ;

JEFCOATE, CR ;

HANNIGAN, EV ;

HOKANSON, JA ;

ZHU, BT .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (20) :9220-9224

[24] Resveratrol analog, 3,4,5,4′-tetrahydroxystilbene, differentially induces pro-apoptotic p53/Bax gene expression and inhibits the growth of transformed cells but not their normal counterparts [J].

Lu, JB ;

Ho, CT ;

Ghai, G ;

Chen, KY .

CARCINOGENESIS, 2001, 22 (02) :321-328

[25]

Lu RQ, 1999, J CELL PHYSIOL, V179, P297, DOI 10.1002/(SICI)1097-4652(199906)179:3<297::AID-JCP7>3.0.CO

[26]

2-P

[27] Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity [J].

Maccarrone, M ;

Lorenzon, T ;

Guerrieri, P ;

Agró, AF .

EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 265 (01) :27-34

[28]

Maggiolini M, 2001, MOL PHARMACOL, V60, P595

[29]

NONOMURA S, 1963, YAKUGAKU ZASSHI, V83, P983

[30] Chronic immune activation and inflammation as the cause of malignancy [J].

O'Byrne, KJ ;

Dalgleish, A .

BRITISH JOURNAL OF CANCER, 2001, 85 (04) :473-483

← 1 2 3 4 →